NHS trusts across England are facing mounting criticism from commercial suppliers over a pattern of late payments that industry representatives say amounts to using private contractors to prop up public sector cash flow. Invoices worth tens of millions of pounds are being settled weeks or months beyond agreed contract terms, with suppliers arguing that hospitals are, in effect, treating them as interest-free lenders while managing their own immediate budget shortfalls.

The criticism is significant because it does not describe a handful of administrative oversights. Representatives from procurement and life-sciences industry bodies say the delays are systemic, spread across multiple regional trusts, and are growing worse as financial pressure on the health service intensifies.

Data collected by supplier groups shows a substantial proportion of NHS invoices remaining unpaid at 30 days past standard terms, with a meaningful share crossing the 60 and 90-day thresholds. Standard commercial contracts typically require settlement within 30 days. The volume of invoices in arrears has increased over the past two financial years, according to figures submitted to parliamentary committees examining NHS procurement conditions.

The businesses absorbing the greatest strain are smaller suppliers in sectors with thin operating margins: specialist medical device manufacturers, life-sciences technology firms, and facilities management contractors providing daily operational services to hospital sites. Unlike larger corporations with access to revolving credit facilities, these companies often rely on prompt payment to meet their own wage bills and supplier obligations. A 60-day payment delay can place them in the same position as a business that has simply not been paid.

Industry bodies have described the current arrangement as unsustainable. The argument they advance is straightforward: financial risk is being transferred from the public sector, which has access to government-backed funding mechanisms, onto private balance sheets that carry no such protection. When a trust delays payment, it is not absorbing additional cost. It is shifting that cost onto the contractor.

The consequences extend beyond individual company balance sheets. Suppliers carrying months of unpaid receivables have reported scaling back research and development programmes, postponing planned hiring, and in some cases raising prices on subsequent contracts to account for the cost of financing their own debt. Each of those outcomes has a downstream effect on the NHS itself. Higher contract prices, reduced supplier investment in product innovation, and a smaller pool of willing contractors all represent costs that ultimately flow back to the public purse.

NHS trusts, for their part, operate within constraints that make late payment less a matter of deliberate policy than structural dysfunction. Trusts across England are managing historic deficits that have accumulated over several years, and many are under formal financial oversight arrangements that restrict their spending decisions. The more immediate problem is the gap between budget allocation and cash availability. A trust may hold a technically balanced budget for a given financial year while simultaneously lacking the liquid funds to settle all outstanding invoices in a given month. In practice, finance directors facing competing obligations tend to prioritise payroll, clinical consumables, and regulatory compliance costs. Commercial invoices from external suppliers fall lower in that hierarchy.

The government has statutory obligations in this area. Public bodies are required under the Prompt Payment Code and the Public Contracts Regulations to pay commercial invoices within 30 days of receipt. Central government departments are required to report payment performance quarterly. NHS trusts have their own reporting obligations, though enforcement has historically been inconsistent and penalties for non-compliance are limited.

The risk that procurement specialists and industry groups now articulate is a longer-term structural one. If payment conditions remain unreliable, established suppliers will begin to price that uncertainty into their bids or withdraw from public procurement frameworks altogether. Fewer bidders means less competition, and less competition means higher contract prices. For a health service already under acute financial strain, that is a deterioration it can ill afford.

‍